Tag Archives: MERS-CoV

BIO Members Collaborate to Produce MERS Treatment

SAB_clean_room

BIO member companies SAB Biotherapeutics, Inc. (SAB) and Novovax, Inc. teamed up with the University of Maryland School of Medicine and the Naval Medical Research Center to treat the deadly Middle East Respiratory Syndrome Coronavirus, known as MERS-CoV. Headquartered in Sioux Falls, S.D., SAB Biotherapeutics, Inc. is an established, biopharmaceutical company that is leading the science and manufacturing of immunoglobulin therapies. Novavax, a clinical-stage vaccine company, is headquartered in Gaithersburg, MD and currently has vaccine candidates to treat a variety of infectious Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

MERS, Patents, and Material Transfer Agreements: What WHO Didn’t Know

Photo by NIAID_Flickr

The outbreak of the Middle East Respiratory Syndrome (MERS-CoV), a SARS like virus has lead to some strong anti-IP statements in Geneva.  A recent article titled “Finding a Fall Guy for Middle East Respiratory Syndrome” in IPWatchdog provides context from multiple news sources and concludes: “An independent review of the claims that patents and the [Material Transfer Agreements] are hindering international MERS-COV research appeared in a May 28, 2013 story in Science Insider. Here’s the lead: Are Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,